NCT02724891

Brief Summary

Patient-reported outcomes are commonly used in healthcare. Examples include validated symptom-based questionnaires and health diaries. In the field of Female Pelvic Medicine and Reconstructive Surgery there are many questionnaires and diaries that have been validated for a paper-based administration. As technology is incorporated into delivery of medical care and research, investigators need to consider how to collect data electronically while ensuring that this new format is equivalent to the paper questionnaires they rely on. In this study, the investigators aim to validate a series of validated questionnaires and symptom diaries administered via the web and smartphone for a more streamlined care for the patients.

Trial Health

90
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Feb 2015

Typical duration for all trials

Geographic Reach
2 countries

5 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2015

Completed
1 year until next milestone

First Submitted

Initial submission to the registry

February 4, 2016

Completed
2 months until next milestone

First Posted

Study publicly available on registry

March 31, 2016

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2018

Completed
Last Updated

April 1, 2019

Status Verified

March 1, 2019

Enrollment Period

3.7 years

First QC Date

February 4, 2016

Last Update Submit

March 28, 2019

Conditions

Keywords

Pelvic Floor Dysfunction

Outcome Measures

Primary Outcomes (4)

  • Test-retest reliability of PFDI-20 in the electronic format

    Subjects will complete the paper and either web-based or smartphone versions of the PFDI-20 with at least a 2 week interval between administration of the 2 versions.

    minimum 2 week interval until subject receives treatment for the condition or up to one year

  • Test-retest reliability of PFIQ-7 in the electronic format

    Subjects will complete the paper and either web-based or smartphone versions of the PFIQ-7 with at least a 2 week interval between administration of the 2 versions.

    minimum 2 week interval until subject receives treatment for the condition or up to one year

  • Test-retest reliability of PISQ-12 in the electronic format

    Subjects will complete the paper and either web-based or smartphone versions of the PISQ-12 with at least a 2 week interval between administration of the 2 versions.

    minimum 2 week interval until subject receives treatment for the condition or up to one year

  • Test-retest reliability of BSS in the electronic format

    Subjects will complete the paper and either web-based or smartphone versions of the BSS with at least a 2 week interval between administration of the 2 versions.

    minimum 2 week interval until subject receives treatment for the condition or up to one year

Study Arms (2)

Arm 1 paper form first

paper questionnaires first then web/smart phone questionnaires after a 2-week washout period

Other: paper formOther: web/smartphone form

Arm 2 web/smartphone form first

web/smart phone questionnaires first then paper questionnaires after a 2-week washout period

Other: paper formOther: web/smartphone form

Interventions

questionnaires in paper form

Arm 1 paper form firstArm 2 web/smartphone form first

questionnaires in web/smartphone

Arm 1 paper form firstArm 2 web/smartphone form first

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

This is a prospective validation study. Subjects will be recruited at their visit to the Female Pelvic Medicine and Reconstructive Surgery offices and clinics at Columbia and Cornell. Demographic information will be collected at the initial visit/enrollment including age, race, parity, and presenting complaint. Questionnaires will be administered based on a randomization scheme. These include: * Pelvic Floor Disorders Inventory short form (PFDI-20) * Pelvic Floor Impact Questionnaire (PFIQ-7) * Pelvic Organ Prolapse/Urinary Incontinence Sexual Function Questionnaire (PISQ-12) * Bristol Stool Scale (BSS) Questionnaires will be administered via paper-based form, web-based, or smartphone app based on randomization scheme.

You may qualify if:

  • Women at least 18 years of age presenting with pelvic floor dysfunction

You may not qualify if:

  • Unable to repeat questionnaires or return to the office in 2 weeks
  • No access to computer/web or smartphone
  • Pregnancy (as gestational age will advance during 2 week time interval and symptoms may change)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (5)

University of Arkansas

Fayetteville, Arkansas, 72701, United States

Location

Columbia University Irving Medical Center

New York, New York, 10032, United States

Location

Houston Methodist Hospital

Houston, Texas, 77030, United States

Location

University of Wisconsin School of Medicine and Public Health

Madison, Wisconsin, 53726, United States

Location

University of Calgary

Calgary, Alberta, T2N 1N4, Canada

Location

Related Publications (1)

  • Grimes CL, Antosh DD, Oliphant S, Yurteri-Kaplan L, Kim-Fine S, Melamud G, Heisler C, Chung DE; Collaborative Research in Pelvic Surgery Consortium (CoRPS). Correlation of Electronic (Web-Based and Smartphone) Administration of Measures of Pelvic Floor Dysfunction: A Randomized Controlled Trial. Female Pelvic Med Reconstr Surg. 2020 Jun;26(6):396-400. doi: 10.1097/SPV.0000000000000713.

Study Officials

  • Cara Grimes, MD

    Columbia University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CROSSOVER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 4, 2016

First Posted

March 31, 2016

Study Start

February 1, 2015

Primary Completion

October 1, 2018

Study Completion

October 1, 2018

Last Updated

April 1, 2019

Record last verified: 2019-03

Data Sharing

IPD Sharing
Will not share

Locations